Items where Author is "Latifnia, M"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 4.

Article

Rezaei Seresht, H and Daei Milani, M and Vahidiyanfar, M and Namaz, MJ and Moallaei, H and Fattahi Abdizadeh, M and Latifnia, M (2020) Protective effects of Vitex pseudo-negundo leaves on diabetic-induced nephropathy in rats. Journal of Basic and Clinical Physiology and Pharmacology.

Fattahi Abdizadeh, M and Latifnia, M (2020) SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial. Clinical infectious diseases.

Latifnia, M (2020) The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment. Journal of Gastroenterology and Hepatology.

Fattahi Abdizadeh, M and Latifnia, M (2019) SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial. Clinical infectious diseases.

This list was generated on Mon Sep 14 09:48:01 2026 +0430.
Medsab is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.